MariMed's Q1 FY2026 shows modest revenue growth and a significant improvement in operating income, turning positive from a loss a year ago, though net loss narrowed. The balance sheet remains leveraged with $82.5M in long-term debt against $6.6M cash, and a recent shareholder vote suggests ongoing capital management activities.
•Revenue grew 4.2% YoY to $39.5M, a modest increase from $37.9M in Q1 FY2025.
•Operating income swung to positive $125K from -$910K a year ago, a 113.7% improvement; net loss narrowed 31.3% to -$3.8M, but EPS remained at -$0.01.
•Cash of $6.6M is low relative to long-term debt of $82.5M, indicating balance sheet stress; equity data is not reported.
•One dilution event in the past 12 months and a June 2026 shareholder vote (8-K) suggest potential capital raises or stock issuances.
Informational summary based on SEC XBRL figures · generated by AI agent. Not investment advice.
A diversified cannabis operator running dispensaries across multiple states alongside branded consumer products and a unique advisory business that licenses its operational expertise to other operators.
🏪 Dispensaries in Massachusetts, Illinois, Maryland, and Delaware cover both medical and adult-use
📋 Advisory and licensing arm generates revenue by helping other cannabis companies navigate state licensing
🍬 Betty's Eddies and Bubby's Baked are consumer-loved edible brands distributed across multiple states
MariMed is a diversified multi-state cannabis operator (MSO) that runs dispensaries across several US states and produces branded consumer products. The company operates in Massachusetts, Illinois, Maryland, and Delaware, serving both medical and adult-use markets. Beyond retail, MariMed has a unique advisory and licensing arm that generates revenue by helping other cannabis companies navigate state licensing processes. This consulting business leverages MariMed's operational expertise to assist other operators in setting up compliant cannabis businesses. The company also manufactures popular edible brands such as Betty's Eddies and Bubby's Baked, which are distributed across multiple states. MariMed's combination of retail, wholesale, and advisory services makes it a versatile player in the US cannabis industry.
What is MariMed's business model?
MariMed operates a multi-faceted business model that includes retail dispensaries, branded product manufacturing, and a consulting arm. The company owns and operates dispensaries in Massachusetts, Illinois, Maryland, and Delaware, generating revenue from both medical and adult-use cannabis sales. In addition to retail, MariMed produces and distributes its own branded edible products, such as Betty's Eddies and Bubby's Baked, which are sold in its own stores and through third-party retailers. A distinctive component of MariMed's model is its advisory and licensing business, which provides expertise to other cannabis companies seeking to obtain state licenses and set up compliant operations. This consulting revenue stream is relatively unique among MSOs and adds a service-based income layer to the company's traditional cannabis operations.
In which states does MariMed operate?
MariMed operates dispensaries in four US states: Massachusetts, Illinois, Maryland, and Delaware. These locations cover both medical and adult-use cannabis markets, allowing the company to serve a broad customer base. Massachusetts and Illinois are established adult-use markets, while Maryland and Delaware have medical cannabis programs. MariMed's presence in these states gives it exposure to diverse regulatory environments and consumer preferences. The company's branded edible products, including Betty's Eddies and Bubby's Baked, are distributed across multiple states beyond its retail footprint, expanding its market reach. MariMed's multi-state strategy helps mitigate risks associated with single-state operations and positions it to capitalize on growth in various regional markets.
What category of cannabis company is MariMed?
MariMed is classified as a US multi-state cannabis operator (MSO). MSOs are companies that operate licensed cannabis businesses in multiple states, taking advantage of the patchwork of state-level legalization in the United States. Unlike Canadian licensed producers (LPs) that often focus on exports and large-scale cultivation, MSOs like MariMed concentrate on domestic retail, cultivation, and product manufacturing within the US. MariMed's operations span dispensaries, branded edibles, and an advisory business, which is a unique differentiator. As an MSO, MariMed competes with other multi-state players such as Curaleaf, Trulieve, and Green Thumb Industries, but its consulting arm sets it apart by providing a non-plant-touching revenue stream. The company's focus on branded consumer products also aligns with trends in the US cannabis market toward premium and consistent offerings.
What are MariMed's notable brands?
MariMed owns and produces two well-known edible brands: Betty's Eddies and Bubby's Baked. Betty's Eddies offers a range of fruit-flavored cannabis-infused chews and gummies, known for their consistent dosing and quality ingredients. Bubby's Baked specializes in baked goods such as cookies and brownies, providing a classic edible experience. Both brands are distributed across multiple states, making them accessible in MariMed's own dispensaries as well as through other retailers. These products are part of MariMed's strategy to build consumer loyalty through recognizable and trusted brand names. The company's focus on edibles complements its retail and advisory operations, creating a vertically integrated approach that captures value from cultivation to point of sale. Betty's Eddies and Bubby's Baked are frequently cited as consumer favorites in their respective markets.
